Thymosin alpha-1 is a small protein, 28-amino acid peptide produced by the thymus gland. Thymosin alpha-1 can increase T-cell and dendritic cell (DC) responses, as well as antibody responses. It can also regulate chemokines and cytokines production and deter steroid-induced apoptosis. Thymosin alpha-1 is part of thymosin fraction 5, which restores immune function in animals that lack thymus glands. Its 28-amino acid peptide fragment originates from an extensive 113-amino acid precursor, prothymosin alpha. Studies have shown it may boost cell-mediated immunity, and may be a possible treatment option for Hepatitis B and C, and may increase immunity against other diseases. The primary function of thymosins in general is the regulation and adjustment of biological responses.
Thymosin alpha-1 is typically delivered in single-use vials of 1.6 mg of lyophilized product. Reconstitution is necessary before use. Reconstitute with 1ml of sterile water. Thymosin alpha-1 is designed to be administered via subcutaneous injection. Do not administer intravenously.
"It is rare to find health professionals who are so willing to educate the patient on what they need to know."